Accreditation

1.0 AMA PRA Category 1 Credit(s)™.
Read the full Accreditation Statement

Target Audience

This activity is intended for general internists and subspecialists.

Description

The Medicine Today, Internal Medicine Webcast Series features on-demand CME webcasts. Each webcast consists of an hour-long video presentation and related questions following the video.

Upon completing the CME activity, the post-test, the evaluation and registration forms, you will have an opportunity to print your CME certificate for your records.

Objectives

At the conclusion of this activity, the participant will be able to:

1. Review the epidemiology of coronary heart disease (CHD) specifically related to African Americans.
2. Discuss unique aspects of CHD risk factors for African Americans.
3. Describe clinical evidence for lipid lowering in African Americans including the recent African American Rosuvastatin Investigation of Efficacy and Safety (ARIES) trial.

Activity Director

William D. Carey, MD
Director, Center for Continuing Education
The Cleveland Clinic Foundation
Cleveland, Ohio

Author / Faculty

Keith C. Ferdinand, MD, FACC

Faculty Disclosure

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:

William D. Carey, MD

The following faculty has indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:

Keith C. Ferdinand, MD, FACC:

Research - AstraZeneca, Merck, NitroMed, Novartis, Pfizer
Consultant - AstraZeneca, NitroMed, Novartis